King Pharmaceuticals is a publicly traded company trading on XNYS, led by CEO Bradford Luke Ledbetter, with a market cap of $82.0M.
Upcoming earnings announcement for King Pharmaceuticals
Past 3 earnings reports for King Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Q4 2025 | -$1.06 | — | $10.2M | — | — |
| Nov 5, 2025 | Q3 2025 | -$1.95 | — | $17.4M | — | — |
| Aug 15, 2025 | Q2 2025 | $15.16 | — | $5.6M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.